| Literature DB >> 30099398 |
Hanna Sandelowsky1,2, Ingvar Krakau1,3, Sonja Modin1, Björn Ställberg4, Sven-Erik Johansson1,2, Anna Nager1.
Abstract
OBJECTIVES: To study the effects of continuing medical education (CME) about chronic obstructive pulmonary disease (COPD) for general practitioners (GPs) by comparing two commonly used CME methods with each other and no CME (reference group).Entities:
Keywords: COPD; case method learning; chronic diseases; cluster randomized controlled trial; continuing medical education; primary care; primary care physicians; professional training; traditional lectures
Mesh:
Year: 2018 PMID: 30099398 PMCID: PMC6089265 DOI: 10.1136/bmjopen-2018-021982
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1Study enrolment, general practitioner part of the PRIMAIR study.
The main characteristics of the participants in the two intervention arms and reference group
| Main characteristics | Baseline | 12 months | |
| Participants | All | Responders | Non-responders |
| Number of participants per PHCC, mean (range) | 7.5 (2–15) | 4.3 (1–10) | |
| Gender, n (%) | |||
| Female | 149 (58) | 81 (61) | 68 (56) |
| Age, mean (range) | 47 (27–69) | 47 (27–68) | 47 (27–69) |
| Degree in family medicine, n (%) | |||
| Specialist in family medicine | 184 (72) | 102 (77) | 82 (67) |
| Training to be a specialist in family medicine | 71 (28) | 31 (23) | 40 (33) |
| Years worked in primary care, mean (range) | 14 (0–41) | 15 (0–37) | 14 (0–41) |
| Asthma/COPD clinic at PHCC, n (%) | |||
| Yes | 114 (45) | 70 (53) | 51 (42) |
| Ownership of PHCC | |||
| Stockholm County Council | 132 (52) | 71 (53) | 61 (50) |
| Private | 123 (48) | 62 (47) | 61 (50) |
| CNI of PHCC’s location | |||
| Mean (SD) | 2.17 (0.78) | 2.03* (0.67) | 2.32* (0.86) |
| Range | 0.92–5.05 | 0.92–5.05 | 0.92–5.05 |
The CNI is based on sociodemographic factors, including percentage of older adults living alone, children under age 5, unemployed people, people with low educational status, single parents, high mobility and foreign-born people. High CNI=high sociodemographic burden; mean CNI in Stockholm County=2.49.
*P of the difference between responders and non-responders <0.05.
CNI, Care Need Index; COPD, chronic obstructive pulmonary disease; PHCC, primary healthcare centre.
Figure 2Development of total scores in the two intervention arms and reference group over time. Total score minimum=0 points, maximum=26 points.
Comparison of the ORs and 95% CIs of scoring 1 or 2 rather than 0 points in the two intervention arms (case methods, CM; traditional lectures, TL) and the reference group (no continuing medical education) 12 months after the intervention
| Question | OR | ||||
| CM and TL vs reference group | CM vs TL | ||||
| CM | TL | Reference group | CM | TL | |
| 1. Diagnostic procedures | 0.55 (0.22 to 1.40) | 0.55 (0.21 to 1.42) | 1 | 1.00 (0.43 to 2.31) | 1 |
| 2. Spirometry interpretation | 1.29 (0.53 to 3.10) | 0.61 (0.24 to 1.55) | 1 | 2.10 (0.90 to 4.95) | 1 |
| 3. Smoking cessation (unmotivated patients) | NA* | ||||
| 4. Acute exacerbation (treatment) | 1.40 (0.57 to 3.45) | 0.77 (0.31 to 1.96) | 1 | 1.81 (0.77 to 4.24) | 1 |
| 5. Acute exacerbation (follow-up) | NA† | ||||
| 6. Smoking cessation (motivated patients) | 0.41 (0.14 to 1.24) | 1.35 (0.39 to 4.69) | 1 | 0.30 (0.10 to 0.88) | 1 |
| 7. Maintenance treatment | 1.04 (0.42 to 2.54) | 0.72 (0.30 to 1.74) | 1 | 1.44 (0.63 to 3.29) | 1 |
| 8. Comorbidity: heart failure | 2.46 (0.79 to 7.66) | 1.70 (0.61 to 4.95) | 1 | 1.45 (0.57 to 3.67) | 1 |
| 9. Follow-up (stable patients) | 2.37 (0.96 to 5.86) | 4.48 (1.51 to 13.3) | 1 | 0.53 (0.20 to 1.40) | 1 |
| 10. Interprofessional interventions | 1.82 (0.59 to 5.61) | 1.42 (0.45 to 4.49) | 1 | 1.29 (0.50 to 3.31) | 1 |
| 11. Suspected respiratory failure | 1.51 (0.62 to 3.72) | 0.97 (0.39 to 2.41) | 1 | 1.57 (0.68 to 3.62) | 1 |
| 12. Multimorbidity, no airway symptoms | 1.36 (0.54 to 3.40) | 0.97 (0.39 to 2.43) | 1 | 1.39 (0.60 to 3.24) | 1 |
| 13. Multimorbidity, airway symptoms | 1.34 (0.53 to 3.37) | 2.64 (1.06 to 6.60) | 1 | 0.51 (0.22 to 1.15) | 1 |
All measures are adjusted for clusters (primary healthcare centres) and total scores at baseline.
*OR not applicable because there was no convergence in the model.
†OR not applicable because the model was questionable.
NA, not applicable.
Figure 3Baseline results per question in the two intervention arms and reference group, presented as per cent of participants who scored 1 or 2 points. Each response was given a score of between 0 and 2 points; the highest possible score was 2 points. On questions 2, 4, 7, 10 and 11, only two scores were possible: 0 or 2 points. COPD, chronic obstructive pulmonary disease.
Figure 4(A–C) Changes over time in the scores per question in each group studied, presented as per cent of participants who scored 1 or 2 points. Each response was given a score of between 0 and 2 points; the highest possible score was 2 points. On questions 2, 4, 7, 10 and 11, only two scores were possible: 0 or 2 points. COPD, chronic obstructive pulmonary disease.